Latest Post

HHS cites increasing rate of variants P.1 and B.351 in recommending use of Regeneron (but no longer Lilly) monoclonal antibody combination in eight states

By Daniel R. Lucey MD, MPH, FIDSA On Wednesday (May 26) the Department of Health and Human Services made the clinically-relevant important update below.  (I anticipate more than these eight states to be included in the weeks and months ahead as the variants P.1. and B.1. 351 continue to spread in the United States). ​“Important […]

More »

Recent Posts

Extra! Extra time to add your two cents . . .

Deadline extended for you to weigh in on Science Speaks coverage Over the last 12 years the IDSA and HIVMA Science Speaks blog has witnessed and covered a world of changes in global infectious diseases research, responses and impacts. As the blog continues to evolve with the times, we want to hear from you. What brings you […]

More »

As substance use disorders rise in the midst of a pandemic, a new law is needed now to facilitate treatment

While America’s epidemic of opioid use was already a burgeoning health crisis, it has worsened markedly since the onset of the COVID-19 pandemic. Between September 2019 and September 2020, the U.S. Centers for Disease Control and Prevention estimates, deaths caused by opioid overdoses have increased by nearly a third. Dr. Ellen Eaton, of the Outpatient-Based […]

More »

Will the China report on 266 patients Nov. 17-Dec. 31, 2019 be made public by China, WHO, or by WHA resolution next week?

By Daniel R. Lucey MD, MPH, FIDSA In a recent Science paper by Pekar, Worobey and colleagues titled “Timing the SARS-CoV-2 index case in Hubei province” the authors conclude “Our results define the period between mid-October and mid-November 2019 as the plausible interval when the first case of SARS-CoV-2 emerged in Hubei province.” Referencing reporting […]

More »
More Recent Posts »

Live Blog Archive

CODEL Video

Click above for a video on our Congressional study tour to Africa, and click here to read more.

HIV

As substance use disorders rise in the midst of a pandemic, a new law is needed now to facilitate treatment

While America’s epidemic of opioid use was already a burgeoning health crisis, it has worsened markedly since the onset of the COVID-19 pandemic. Between September 2019 […]

Tuberculosis

CDC announces publication of TB treatment trial results showing four month regimen as effective as six month

The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]

Research & Development

Can unprecedented success in COVID vaccine development boost prospects for an HIV vaccine?

By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]

Policy

As environmental destruction accelerates the spread of emerging infections, we need to talk

By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]